- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the integrated stress response in hematologic malignancies ; volume:11 ; number:1 ; day:8 ; month:11 ; year:2022 ; pages:1-15 ; date:12.2022
Experimental hematology & oncology ; 11, Heft 1 (8.11.2022), 1-15, 12.2022
- Urheber
-
Nwosu, Gus O.
Powell, Jason A.
Pitson, Stuart M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-022-00348-0
- URN
-
urn:nbn:de:101:1-2023012210473554455334
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:28 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nwosu, Gus O.
- Powell, Jason A.
- Pitson, Stuart M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hematologic malignancies
Targeting CD22 for B-cell hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Hematologic malignancies
Targeting CD22 for B-cell hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
Hematologic malignancies
Targeting CD22 for B-cell hematologic malignancies
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies